Estimates of the variety of specfficities of anti-influenza hemagglutinin antibodies in postinfection human sera taken between 1969 and 1971 and in 1978 were made by using Fab fragments of defined monoclonal antibodies in competitive virus-binding assays. The results obtained with the sera taken between 1969 and 1971 indicated that different sera contained antibodies with different ranges of specificities, whereas the 1978 sera mainly contained a broad range of antibodies. The results are discussed in relation to the mechanism of antigenic drift in influenza virus, the commonly observed antigenic heterogeneity of influenza virus isolates, and the efficacy of antiinfluenza vaccination.
Antigenic variations among the hemagglutinins (HAs) of Hong Kong (H3 subtype) influenza viruses result from differences in amino acid sequences at a number of positions in the peripheral globular regions of the molecules (22, 23) . In natural antigenic variants isolated from infected humans between 1968 and 1983, 86 (21%) amino acid substitutions were observed in the HA, polypeptides, which exclusively make up these globular regions, as compared with 6 (2%) in the HA2 components, which form the base and central stem of the molecule (1, 16, 21) . This drift in amino acid sequence and antigenicity is commonly considered (for reviews, see references 17 and 22) (6) , and A/Texas/1/77 (H3N2) was used as the representative 1977 virus. Antigenic variants used to define the specificities of the monoclonal antibodies were obtained by mixing equal volumes of allantoic fluid containing virus and undiluted ascitic fluid containing monoclonal antibodies and using the mixture as the inoculum. Variants obtained were cloned by limit dilution. Viruses were purified as described previously (18) .
Nucleotide sequence analyses. Sequences of the genes for the HAs of the monoclonal antibody-selected antigenic variants were determined by the dideoxynucleotide chainterminating procedure of Sanger et al. (14) as described elsewhere (2) . Fig. 1 and 2 ), which indicated that the antibodies recognized nonoverlapping determinants on the respective HAs, and (ii) by an analysis of the complete nucleotide sequences of the genes for the HAs of the antigenic variants selected for growth in the presence of the different monoclonal antibodies. The three anti-X-31 antibodies recognized residues 144, 157, and 198 of HA1 in antigenic region A and two distinct areas of region B, respectively (2, 23) , and the three anti-A/Texas/1/77 antibodies recognized residues 78, 144, and 198 of HA1 in regions E, A, and B, respectively (Table 1) . It should be noted that although antibodies HC31(198) and HC59(198) recognized the same residues in X-31 and AlTexas/1/77 HAs, respectively, these residues were not antigenically equivalent in the different HAs, and the antibodies only reacted with the homologous antigens.
Radioimmunoassays. The results of the radioimmunoassays of the sera taken between 1969 and 1971 are shown in Table 2 . They indicated that when a 40% inhibition of 1251I-Fab binding was used as an arbitrary minimum inhibition at any serum dilution, 33% of the sera contained antibodies of all three specificities tested, 50% lacked antibodies of only one specificity tested, and 17% appeared to lack antibodies of two of three specificities tested. For the 1977 virus and the 1978 sera (Table 3) , 78% of the sera contained antibodies of all three specificities tested, and the remaining 22% lacked antibodies of only one specificity tested. DISCUSSION We attempted in these experiments to compare the antibody responses of different individuals to influenza virus by determining whether sera taken from them after infection contained antibodies of certain specificities. The results presented do not provide information on the actual range of anti-HA antibody specificities present in the sera, nor do they represent quantitative estimates of the relative abundance in sera of antibodies with different specificities. However, since they indicate that sera differ in their abilities to inhibit the binding to virus of different Fab fragments from monoclonal antibodies, they allow the simple conclusion that individuals respond differently to infection by producing antibodies with different ranges of specificities; this was most clearly seen in the results obtained with sera taken in the early years of Hong Kong influenza (1969 to 1971). Of these sera, only 33% contained antibodies of all three specificities tested, a further 50% had antibodies of two of the specificities tested, and the remaining 17% had antibodies of only one of the specificities tested. Since the numbers of sera negative in tests with any one specific Fab fragment were about equal and since the affinities of the Fab fragments for the HAs were also similar (Table 1 ), it appears that no single antigenic region of the molecule was generally recognized as immunodominant. The results obtained with sera taken in 1978 suggest that the majority contained a broad range of antibody specificities and, consequently, the possibility that this may have contributed to the decrease in the number of significant outbreaks of disease since 1975. This possibility was not directly addressed in these studies, however, primarily because of the restricted range of specificities of the Fab fragments used in the tests and because direct estimates of the infectivity-neutralizing capacity of the sera were not made.
Other observations which suggest variations in the range of specificities of anti-HA antibodies in individual animals have been made before. For example, analyses of the frequency of isolation of cloned cells producing anti-HA antibodies of a particular specificity indicated variations in the antibody repertoire of individual mice (19, 20) . Variations have also been frequently observed in the specificities of anti-HA antibodies in individual postinfection ferret sera, commonly used as a source of strain-specific reference 1968, 1972, and 1975 (23) . In this case, epidemiologically significant antigenic variants would arise by a process of sequential change during a series of reinfections of individuals with restricted ranges of antibodies. The frequency with which they occurred would depend on the proportions of the population with different ranges of antibody specificities.
Finally, two characteristics of influenza viruses warrant consideration together with the results presented here. Analyses of influenza viruses isolated from humans with anti-HA monoclonal antibodies indicate that at anytime the viruses in circulation are antigenically heterogeneous (e.g., 13 ). This heterogeneity may be a reflection of differences in the responses of individuals to infection and the consequent differences in the selection pressures which they generate. It has also been observed that protective immunity is developed in considerably less than 100% of influenza vaccinees (between 50 and 75%, depending on the study), although the vaccines used are immunogenically potent. If the immune response to the noninfectious vaccines used varies with the individual vaccinee in a similar fashion to the responses to infection reported here, then the inefficiency of vaccination may be a direct consequence.
